| ||
| ||
| RPT-Seattle Genetics says leukemia drug fails trial Reuters LOS ANGELES, Sept 13 (Reuters) - Seattle Genetics (SGEN.O) said on Monday it would discontinue development of its experimental drug lintuzumab after a trial found it did not extend the lives of patients with acute myeloid leukemia and its shares fell ... See all stories on this topic » | ||
| Donald Berwick, Obama's Top Health Care Official, Takes the Stage TIME By Kate Pickert Monday, Sep. 13, 2010 Goodman Media International / AP Donald Berwick, the new and controversial head of Medicare and Medicaid, has a bum knee. The trouble started about 40 years ago when Berwick, playing soccer, suffered a painful ... See all stories on this topic » | ||
| Sebelius Cautions Insurers on Rate Hikes HealthLeaders Media In a sternly worded message to health insurers, Health and Human Services Secretary Kathleen Sebelius said last week that the federal government will not "stand idly by as insurers blame their premium hikes and increased profits" on changes related to ... See all stories on this topic » | ||
| Health Highlights: Sept. 10, 2010 BusinessWeek US government officials announced Friday that researchers at the National Institutes of Health (NIH) will resume working with embryonic stem cells after an appeals court issued a temporary suspension of a judge's recent ban. ... See all stories on this topic » | ||
| AAP Urges Health Care Pros to Get Flu Shots Food Consumer According to a new policy statement per the American Pediatric Academy website, the agency is recommending that all health care professionals be "required to receive an annual influenza vaccine." The policy statement, which is entitled "Recommendation ... See all stories on this topic » | ||
| Which state eats more fruit than California? OCRegister By LANDON HALL Forty-point-one percent of Californians eat fruit at least twice a day, behind DC's 40.2 percent. In the vegetable-ingestion department, however, California gets squashed: We rank 25th out of the states and DC, with 26.8 percent of ... See all stories on this topic » | ||
| Hopes fade for Roche and Ipsen's new diabetes drug Reuters By Ben Hirschler LONDON, Sept 13 (Reuters) - Shares in French drugmaker Ipsen (IPN.PA) fell 3 percent on Monday as remaining hopes faded for its new diabetes drug taspoglutide, being developed with Roche (ROG.VX). Roche stopped giving patients the ... See all stories on this topic » |
Tip: Use a minus sign (-) in front of terms in your query that you want to exclude.Learn more.
Remove this alert.
Create another alert.
Manage your alerts.
No comments:
Post a Comment